Transcriptional programs regulated by p63 in normal epithelium and tumors
- PMID: 17297308
- DOI: 10.4161/cc.6.3.3801
Transcriptional programs regulated by p63 in normal epithelium and tumors
Abstract
The transcription factor p63 belongs to a family of regulatory proteins that bind DNA in a sequence-specific manner, close to a target gene, to activate or repress its transcription. These proteins display a striking conservation of functional domains, but are differentially involved in regulating cellular processes. Nearly a decade after the discovery of p63, its critical role for proper epithelial development, maintenance and tumorigenesis is widely recognized. Several important cellular endpoints have been linked to p63 regulation in epithelium, including differentiation, cell fate specification, proliferation, survival, senescence, apoptosis, cell-cell and cell-matrix interaction programs. Although a large number of genes have been associated with p63-dependent regulation, only a few of these have been validated as direct p63 transcriptional targets. The challenge still remains to define the p63 transcriptome in epithelial cells, and to dissect the cellular mechanisms used to modulate the expression of this transcriptional profile. In this article we will review current knowledge regarding the basic mechanisms used by p63 to regulate gene expression. Also, we will discuss specific p63-regulated biological endpoints in epithelial cells and the specific genes that have been linked to p63 regulation in these particular contexts.
Similar articles
-
p63 transcriptional regulation of epithelial integrity and cancer.Cell Cycle. 2007 Feb 1;6(3):240-5. doi: 10.4161/cc.6.3.3803. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17297296 Review.
-
p63, cellular senescence and tumor development.Cell Cycle. 2007 Feb 1;6(3):305-11. doi: 10.4161/cc.6.3.3794. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17224650 Review.
-
The roles of p63 in cancer.Cell Cycle. 2007 Feb 1;6(3):300-4. doi: 10.4161/cc.6.3.3793. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17264676 Review.
-
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.Cancer Res. 2006 Oct 1;66(19):9362-8. doi: 10.1158/0008-5472.CAN-06-1619. Cancer Res. 2006. PMID: 17018588
-
Hitting the numbers: the emerging network of p63 targets.Cell Cycle. 2007 Feb 1;6(3):233-9. doi: 10.4161/cc.6.3.3802. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17297297 Review.
Cited by
-
Structural diversity of p63 and p73 isoforms.Cell Death Differ. 2022 May;29(5):921-937. doi: 10.1038/s41418-022-00975-4. Epub 2022 Mar 21. Cell Death Differ. 2022. PMID: 35314772 Free PMC article. Review.
-
Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling.Front Physiol. 2014 Jun 3;5:166. doi: 10.3389/fphys.2014.00166. eCollection 2014. Front Physiol. 2014. PMID: 24917821 Free PMC article. Review.
-
KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma.Front Oncol. 2021 May 31;11:686678. doi: 10.3389/fonc.2021.686678. eCollection 2021. Front Oncol. 2021. PMID: 34136411 Free PMC article.
-
A composite enhancer regulates p63 gene expression in epidermal morphogenesis and in keratinocyte differentiation by multiple mechanisms.Nucleic Acids Res. 2015 Jan;43(2):862-74. doi: 10.1093/nar/gku1396. Epub 2015 Jan 7. Nucleic Acids Res. 2015. PMID: 25567987 Free PMC article.
-
Expression Patterns of Gli-1, Pleckstrin Homology-Like Domain, Family A, Member 1, Transforming Growth Factor-β1/β2, and p63 in Sebaceous and Follicular Tumors.Ann Dermatol. 2014 Dec;26(6):713-21. doi: 10.5021/ad.2014.26.6.713. Epub 2014 Nov 26. Ann Dermatol. 2014. PMID: 25473223 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources